THE EFFECT OF SODIUM ALENDRONATE GEL ON OSSEOINTEGRATION OF SUBMERGED DENTAL IMPLANTS
Hotieba, A., Sharara, A., Osman, S. (2020). THE EFFECT OF SODIUM ALENDRONATE GEL ON OSSEOINTEGRATION OF SUBMERGED DENTAL IMPLANTS. EKB Journal Management System, 45(1), 1-6. doi: 10.21608/adjalexu.2020.79855
Ahmed A. Hotieba; Ahmed A. Sharara; Saeeda M. Osman. "THE EFFECT OF SODIUM ALENDRONATE GEL ON OSSEOINTEGRATION OF SUBMERGED DENTAL IMPLANTS". EKB Journal Management System, 45, 1, 2020, 1-6. doi: 10.21608/adjalexu.2020.79855
Hotieba, A., Sharara, A., Osman, S. (2020). 'THE EFFECT OF SODIUM ALENDRONATE GEL ON OSSEOINTEGRATION OF SUBMERGED DENTAL IMPLANTS', EKB Journal Management System, 45(1), pp. 1-6. doi: 10.21608/adjalexu.2020.79855
Hotieba, A., Sharara, A., Osman, S. THE EFFECT OF SODIUM ALENDRONATE GEL ON OSSEOINTEGRATION OF SUBMERGED DENTAL IMPLANTS. EKB Journal Management System, 2020; 45(1): 1-6. doi: 10.21608/adjalexu.2020.79855

THE EFFECT OF SODIUM ALENDRONATE GEL ON OSSEOINTEGRATION OF SUBMERGED DENTAL IMPLANTS

Alexandria Dental Journal
Article 1, Volume 45, Issue 1, April 2020, Page 1-6  XML PDF (239.31 K)
Document Type: Original Article
DOI: 10.21608/adjalexu.2020.79855
View on SCiNiTO View on SCiNiTO
Authors
Ahmed A. Hotieba email 1; Ahmed A. Sharara2; Saeeda M. Osman2
1BDS,2011, Faculty of Dentistry, Alexandria University, Egypt.
2Professor of Oral and Maxillofacial Surgery, Faculty of Dentistry, Alexandria University, Egypt.
Abstract
INTRODUCTION: A plenty of materials have been used to increase the success rate, decrease time needed for osseointegration, stimulate bone formation around dental implants. Bisphosphonates increase bone mineral density by inhibiting osteoclast-mediated bone resorption. Alendronate sodium hydrate is a bisphosphonate that potently inhibits bone resorption and is used to treat osteoporosis. A 1% sodium alendronate gel is manufactured and tested in order to accelerate osseointegration around dental implants.
OBJECTIVES: This study aims to compare clinically and radiographically the osseointegration for 2 groups of submerged dental implants both in upper anterior and premolar region, first group with the use of local sodium alendronate gel prior to placement of dental implant and the second group without.
MATERIALS AND METHODS: A clinical trial on 24 implants divided into 2 groups indicated for dental implant placement in the upper anterior and premolar region selected from the outpatient clinic of the Oral and Maxillofacial department, Faculty of Dentistry, Alexandria University. For the test group 12 implants were placed with sodium alendronate gel just prior to implant placement. For control group 12 implants were placed without sodium alendronate gel.
RESULTS: On the 12 week the resonance frequency analysis (RFA) median records were (55.50, 54.0) and the Mean ± SD (55.08 ± 4.94, 54.67 ± 5.69) for the control group and test group, respectively. The bisphosphonate-coated implants showed an increase in implant stability from 0 to 12 weeks more than the control's measures. On the 12 week, the mean peri-implant bone density value was 1417.92 ± 310.54 for control group and 1550.25 ± 286.15 for test group. These increases in the bone density were higher in test group than the control group.
CONCLUSIONS: Using sodium alendronate gel with delayed implant placement could enhance the osseointegration around dental implants.
Keywords
Sodium Alendronate gel; osseointegration; cone beam CT; implants stability; bone density
References
  1. Ioannou AL, Kotsakis GA, McHale MG, Lareau DE, Hinrichs JE, Romanos GE. Soft tissue surgical procedures for optimizing anterior implant esthetics. Int J Dent. 2015;2015:1-9.
  2. Brånemark P-I, Breine U, Adell R, Hansson B, Lindström J, Ohlsson Å. Intra-osseous anchorage of dental prostheses: I. Experimental studies. Scand J Plast Reconstr Surg. 1969;3:81-100.
  3. 3-Misch C, Wang H. Immediate occlusal loading for fixed prostheses in implant dentistry. Dent Today. 2003;22:50-6.
  4. Mundy GR, Yoneda T. Bisphosphonates as anticancer drugs. N Engl J Med. 1998;339:398-400.
  5. Abtahi J, Tengvall P, Aspenberg P. Bisphosphonate coating might improve fixation of dental implants in the maxilla: a pilot study. Int J Oral Maxillofac Surg. 2010;39:673-7.
  6. Abtahi J, Tengvall P, Aspenberg P. A bisphosphonatecoating improves the fixation of metal implants in human bone. A randomized trial of dental implants. Bone. 2012;50:1148-51.
  7. Cuairán C, Campbell PM, Kontogiorgos E, Taylor RW, Melo AC, Buschang PH. Local application of zoledronate enhances miniscrew implant stability in dogs. Am J Orthod Dentofacial Orthop. 2014;145:737-49.
  8. Jakobsen T, Baas J, Kold S, Bechtold JE, Elmengaard B, Søballe K. Local bisphosphonate treatment increases fixation of hydroxyapatite-coated implants inserted with bone compaction. J Orthop Res. 2009;27:189-94.
  9. Skoglund B, Holmertz J, Aspenberg P. Systemic and local ibandronate enhance screw fixation. J Orthop Res. 2004;22:1108-13.
  10. Devogelaer J-P, Broll H, Correa-Rotter R, Cumming D, De Deuxchaisnes CN, Geusens P, et al. Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis. Bone. 1996;18:141-50.
  11. Tucci JR, Tonino RP, Emkey RD, Peverly CA, Kher U, Santora AC. Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis. Am J Med. 1996;101:488-501.
  12. Reddy GT, Kumar TP, Veena K. Formulation and evaluation of alendronate sodium gel for the treatment of bone resorptive lesions in periodontitis. Drug Deliv. 2005;12:217-22.
  13. McCormack HM, David JdL, Sheather S. Clinical applications of visual analogue scales: a critical review. Psychol Med. 1988;18:1007-19.
  14. Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran pathologic basis of disease, professional edition ebook. 9th ed. Elsevier Health Sciences; 2014.
  15. Mombelli A, Lang NP. Clinical parameters for the evaluation of dental implants. Periodontol 2000. 1994;4:81-6.
  16. Porter JA, von Fraunhofer JA. Success or failure of dental implants? A literature review with treatment considerations. Gen Dent. 2005;53:423-33.
  17. Pranskunas M, Poskevicius L, Juodzbalys G, Kubilius R, Jimbo R. Influence of peri-implant soft tissue condition and plaque accumulation on peri-implantitis: a systematic review. J Oral Maxillofac Res. 2016;7:1-9.
  18. Kajiwara H, Yamaza T, Yoshinari M, Goto T, Iyama S, Atsuta I, et al. The bisphosphonate pamidronate on the surface of titanium stimulates bone formation around tibial implants in rats. Biomaterials. 2005;26:581-7.
  19. Albrektsson T, Jansson T, Lekholm U. Osseointegrated dental implants. Dent Clin North Am. 1986;30:151-74.
  20. Parithimarkalaignan S, Padmanabhan TV. Osseointegration: An Update. J Indian Prosthodont Soc. 2013;13:2-6.
  21. Hilding M, Aspenberg P. Postoperative clodronate decreases prosthetic migration: 4–year follow-up of a randomized radiostereometric study of 50 total knee patients. Acta Orthop. 2006;77:912-6.
  22. Meraw SJ, Reeve CM. Qualitative analysis of peripheral peri-implant bone and influence of alendronate sodium on early bone regeneration. J Periodontol. 1999;70:1228-33.
  23. Meraw SJ, Reeve CM, Wollan PC. Use of alendronate in peri-implant defect regeneration. J Periodontol. 1999;70:151-8.
  24. Stadelmann VA, Terrier A, Gauthier O, Bouler J-M, Pioletti DP. Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. A pilot study. Eur Cell Mater. 2008;16:10-6.
  25. Kwak HB, Kim JY, Kim KJ, Choi M-K, Kim J-J, Kim KM, et al. Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss. Biol Pharm Bull. 2009;32:1193-8.
  26. Denissen H, Montanari C, Martinetti R, van Lingen A, van den Hooff A. Alveolar bone response to submerged bisphosphonate-complexed hydroxyapatite implants. J Periodontol. 2000;71:279-86.
  27. Toksvig-Larsen S, Aspenberg P. Bisphosphonate-coated external fixation pins appear similar to hydroxyapatitecoated pins in the tibial metaphysis and to uncoated pins in the shaft: a randomized trial. Acta Orthop. 2013;84:314-8.
  28. Wermelin K, Tengvall P, Aspenberg P. Surface-bound bisphosphonates enhance screw fixation in rats—increasing effect up to 8 weeks after insertion. Acta Orthop. 2007;78:385-92.
  29. McKenzie K, Bobyn JD, Roberts J, Karabasz D, Tanzer M. Bisphosphonate remains highly localized after elution from porous implants. Clin Orthop Relat Res. 2011;469:514-22.
  30. Russell R, Watts N, Ebetino F, Rogers M. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int. 2008;19:733-59
Statistics
Article View: 614
PDF Download: 692